81 results
Page 2 of 5
8-K
EX-99.1
qxq 8mqx6e
11 May 23
Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study
9:24am
8-K
EX-3.1
tqw8ok dwf
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
EX-99.2
a5e do81a6
9 Aug 22
Olema Oncology Reports Second Quarter 2022 Financial Results and Provides Corporate Update
12:00am
S-3
EX-4.3
cvigvsvayy qf
28 Feb 22
Shelf registration
6:34pm
S-3
f05ld
28 Feb 22
Shelf registration
6:34pm
10-Q
rlztji43zkqwbr91
11 May 21
Quarterly report
4:22pm
DEF 14A
8j0rwilr06177
27 Apr 21
Definitive proxy
4:06pm
10-K
au13cd8jq5rd6e
17 Mar 21
Annual report
4:21pm